Biotron Limited
Biotron Limited
Your view on BIT.AX
Overview
What the company does, where it operates, and who runs it.
About Biotron Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Michelle Miller GCertAppFin
- Headquarters
- 66 Hunter Street, Sydney, NSW, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Michelle Miller GCertAppFin
- Headquarters
- 66 Hunter Street, Sydney, NSW, AU
Biotron Limited is an Australian biotechnology firm dedicated to the creation and market introduction of small molecule therapies designed to combat a range of viral illnesses.
Its flagship antiviral compound, BIT225, is currently undergoing Phase II clinical evaluations for addressing infections caused by SARS-CoV-2, HIV-1, and the hepatitis C virus. Established in 1999, the company operates from its main office in Sydney, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Biotron Limited. Starting points for Biotron Limited: beta -0.61 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Biotron Limited. Biotron Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Biotron Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Biotron Limited. Biotron Limited has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 1AD.AXAdAlta Limited | Healthcare | Biotechnology | — | ||
| ACR.AXAcrux Limited | Healthcare | Biotechnology | — | ||
| ADR.AXAdherium Limited | Healthcare | Medical - Devices | — | ||
| BGT.AXBio-Gene Technology Limited | Basic Materials | Agricultural Inputs | — | ||
| CHM.AXChimeric Therapeutics Limited | Healthcare | Biotechnology | — | ||
| GLH.AXGlobal Health Limited | Healthcare | Medical - Care Facilities | — | ||
| IBX.AXImagion Biosystems Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| OVIDOvid Therapeutics Inc. | Healthcare | NASDAQ | $426.5M | ||
| OXBOFOxford BioDynamics Plc | Healthcare | OTC | $4.3M | ||
| OZYMFStrategic Partners A/S | Healthcare | OTC | $3.7M | ||
| PAB.AXPatrys Limited | Healthcare | ASX | — | ||
| PALIPalisade Bio, Inc. | Healthcare | NASDAQ | $168.9M | ||
| PANCPanacos Pharmaceuticals, Inc. | Healthcare | OTC | $5,367 | ||
| PAR.AXParadigm Biopharmaceuticals Limited | Healthcare | ASX | — | ||
| PARDPoniard Pharmaceuticals, Inc. | Healthcare | OTC | $150 | ||
| PASGPassage Bio, Inc. | Healthcare | NASDAQ | $12.9M | ||
| PBIGFParadigm Biopharmaceuticals Limited | Healthcare | OTC | $87.9M | ||
| PBLAPanbela Therapeutics, Inc. | Healthcare | OTC | $53,889 | ||
| PBLSParabilis Medicines, Inc. | Healthcare | NASDAQ | $3.5B | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Biotron Limited.